-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Olema Pharmaceuticals with Buy Rating, Announces Price Target of $48

Benzinga·02/11/2026 15:20:25
Listen to the news
Stifel analyst Laura Prendergast initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Price Target of $48.